earnings digest health imclone systems inc reuters sales of cancer drug erbitux imclone systems inc s only product rose to &# million but didnt meet expectations the new york biotechnology company receives of those sales in the u s while partner bristol myers squibb co receives the rest imclones total revenue for the fourth quarter was up to &# million sales of the drug are under pressure from vectibix which is made by amgen inc erbitux is used in the treatment of colon cancer and has also been approved to treat head and neck cancer 
